ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ophthalmic Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13H8167
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and Japan Ophthalmic Medicine Market Insights Forecast to 2027
BUY CHAPTERS

Global Ophthalmic Medicine Market Research Report 2025

Code: QYRE-Auto-13H8167
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon
Mentholatum

Ophthalmic Medicine Market Size

The global market for Ophthalmic Medicine was valued at US$ 2004 million in the year 2024 and is projected to reach a revised size of US$ 2770 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Ophthalmic Medicine Market

Ophthalmic Medicine Market

There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Medicine.
The Ophthalmic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ophthalmic Medicine Market Report

Report Metric Details
Report Name Ophthalmic Medicine Market
Accounted market size in year US$ 2004 million
Forecasted market size in 2031 US$ 2770 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Anti-fatigue and Dryness
  • Cataract
  • Anti-infective
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ophthalmic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ophthalmic Medicine Market growing?

Ans: The Ophthalmic Medicine Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Ophthalmic Medicine Market size in 2031?

Ans: The Ophthalmic Medicine Market size in 2031 will be US$ 2770 million.

Who are the main players in the Ophthalmic Medicine Market report?

Ans: The main players in the Ophthalmic Medicine Market are Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum

What are the Application segmentation covered in the Ophthalmic Medicine Market report?

Ans: The Applications covered in the Ophthalmic Medicine Market report are Anti-fatigue and Dryness, Cataract, Anti-infective

What are the Type segmentation covered in the Ophthalmic Medicine Market report?

Ans: The Types covered in the Ophthalmic Medicine Market report are Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

Recommended Reports

Ophthalmology Drugs

Ophthalmic Disease Treatment

Ophthalmic Devices & Delivery

1 Ophthalmic Medicine Market Overview
1.1 Product Definition
1.2 Ophthalmic Medicine by Type
1.2.1 Global Ophthalmic Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Eye Drops
1.2.3 Eye Ointment
1.2.4 Gelling Agent
1.2.5 Tablet
1.2.6 Injection
1.3 Ophthalmic Medicine by Application
1.3.1 Global Ophthalmic Medicine Market Value by Application (2024 VS 2031)
1.3.2 Anti-fatigue and Dryness
1.3.3 Cataract
1.3.4 Anti-infective
1.4 Global Ophthalmic Medicine Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Medicine Revenue 2020-2031
1.4.2 Global Ophthalmic Medicine Sales 2020-2031
1.4.3 Global Ophthalmic Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ophthalmic Medicine Market Competition by Manufacturers
2.1 Global Ophthalmic Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ophthalmic Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ophthalmic Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ophthalmic Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Medicine, Product Type & Application
2.7 Global Key Manufacturers of Ophthalmic Medicine, Date of Enter into This Industry
2.8 Global Ophthalmic Medicine Market Competitive Situation and Trends
2.8.1 Global Ophthalmic Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ophthalmic Medicine Players Market Share by Revenue
2.8.3 Global Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ophthalmic Medicine Market Scenario by Region
3.1 Global Ophthalmic Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ophthalmic Medicine Sales by Region: 2020-2031
3.2.1 Global Ophthalmic Medicine Sales by Region: 2020-2025
3.2.2 Global Ophthalmic Medicine Sales by Region: 2026-2031
3.3 Global Ophthalmic Medicine Revenue by Region: 2020-2031
3.3.1 Global Ophthalmic Medicine Revenue by Region: 2020-2025
3.3.2 Global Ophthalmic Medicine Revenue by Region: 2026-2031
3.4 North America Ophthalmic Medicine Market Facts & Figures by Country
3.4.1 North America Ophthalmic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ophthalmic Medicine Sales by Country (2020-2031)
3.4.3 North America Ophthalmic Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Medicine Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ophthalmic Medicine Sales by Country (2020-2031)
3.5.3 Europe Ophthalmic Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Ophthalmic Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ophthalmic Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Ophthalmic Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ophthalmic Medicine Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ophthalmic Medicine Sales by Country (2020-2031)
3.7.3 Latin America Ophthalmic Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ophthalmic Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ophthalmic Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Medicine Sales by Type (2020-2031)
4.1.1 Global Ophthalmic Medicine Sales by Type (2020-2025)
4.1.2 Global Ophthalmic Medicine Sales by Type (2026-2031)
4.1.3 Global Ophthalmic Medicine Sales Market Share by Type (2020-2031)
4.2 Global Ophthalmic Medicine Revenue by Type (2020-2031)
4.2.1 Global Ophthalmic Medicine Revenue by Type (2020-2025)
4.2.2 Global Ophthalmic Medicine Revenue by Type (2026-2031)
4.2.3 Global Ophthalmic Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Ophthalmic Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ophthalmic Medicine Sales by Application (2020-2031)
5.1.1 Global Ophthalmic Medicine Sales by Application (2020-2025)
5.1.2 Global Ophthalmic Medicine Sales by Application (2026-2031)
5.1.3 Global Ophthalmic Medicine Sales Market Share by Application (2020-2031)
5.2 Global Ophthalmic Medicine Revenue by Application (2020-2031)
5.2.1 Global Ophthalmic Medicine Revenue by Application (2020-2025)
5.2.2 Global Ophthalmic Medicine Revenue by Application (2026-2031)
5.2.3 Global Ophthalmic Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Ophthalmic Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novaliq
6.1.1 Novaliq Company Information
6.1.2 Novaliq Description and Business Overview
6.1.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novaliq Ophthalmic Medicine Product Portfolio
6.1.5 Novaliq Recent Developments/Updates
6.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
6.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
6.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
6.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Zhejiang Shapuaisi Pharmaceutical
6.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
6.3.2 Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
6.3.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
6.4 Chengdu Kanghong Pharmaceutical Group
6.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
6.4.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview
6.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
6.4.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
6.5 Santen Pharmaceutica
6.5.1 Santen Pharmaceutica Company Information
6.5.2 Santen Pharmaceutica Description and Business Overview
6.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
6.5.5 Santen Pharmaceutica Recent Developments/Updates
6.6 Bausch Health
6.6.1 Bausch Health Company Information
6.6.2 Bausch Health Description and Business Overview
6.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bausch Health Ophthalmic Medicine Product Portfolio
6.6.5 Bausch Health Recent Developments/Updates
6.7 Alcon NV
6.7.1 Alcon NV Company Information
6.7.2 Alcon NV Description and Business Overview
6.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Alcon NV Ophthalmic Medicine Product Portfolio
6.7.5 Alcon NV Recent Developments/Updates
6.8 Mentholatum
6.8.1 Mentholatum Company Information
6.8.2 Mentholatum Description and Business Overview
6.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mentholatum Ophthalmic Medicine Product Portfolio
6.8.5 Mentholatum Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Medicine Industry Chain Analysis
7.2 Ophthalmic Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Medicine Production Mode & Process Analysis
7.4 Ophthalmic Medicine Sales and Marketing
7.4.1 Ophthalmic Medicine Sales Channels
7.4.2 Ophthalmic Medicine Distributors
7.5 Ophthalmic Medicine Customer Analysis
8 Ophthalmic Medicine Market Dynamics
8.1 Ophthalmic Medicine Industry Trends
8.2 Ophthalmic Medicine Market Drivers
8.3 Ophthalmic Medicine Market Challenges
8.4 Ophthalmic Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon
Mentholatum
List of Tables
 Table 1. Global Ophthalmic Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ophthalmic Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ophthalmic Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ophthalmic Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ophthalmic Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ophthalmic Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ophthalmic Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ophthalmic Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ophthalmic Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ophthalmic Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ophthalmic Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Ophthalmic Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ophthalmic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ophthalmic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ophthalmic Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ophthalmic Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Ophthalmic Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ophthalmic Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Ophthalmic Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ophthalmic Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Ophthalmic Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ophthalmic Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Ophthalmic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ophthalmic Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ophthalmic Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ophthalmic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ophthalmic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ophthalmic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ophthalmic Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ophthalmic Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ophthalmic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ophthalmic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ophthalmic Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ophthalmic Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ophthalmic Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ophthalmic Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ophthalmic Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ophthalmic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ophthalmic Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ophthalmic Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ophthalmic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ophthalmic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ophthalmic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ophthalmic Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ophthalmic Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ophthalmic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ophthalmic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ophthalmic Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Ophthalmic Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Ophthalmic Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Ophthalmic Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Ophthalmic Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ophthalmic Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ophthalmic Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Ophthalmic Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Ophthalmic Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ophthalmic Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ophthalmic Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Ophthalmic Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Ophthalmic Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Ophthalmic Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Ophthalmic Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ophthalmic Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ophthalmic Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Ophthalmic Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Ophthalmic Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ophthalmic Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Novaliq Company Information
 Table 71. Novaliq Description and Business Overview
 Table 72. Novaliq Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novaliq Ophthalmic Medicine Product
 Table 74. Novaliq Recent Developments/Updates
 Table 75. Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
 Table 76. Shenyang Xingqi Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 77. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product
 Table 79. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 80. Zhejiang Shapuaisi Pharmaceutical Company Information
 Table 81. Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
 Table 82. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product
 Table 84. Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
 Table 85. Chengdu Kanghong Pharmaceutical Group Company Information
 Table 86. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
 Table 87. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product
 Table 89. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
 Table 90. Santen Pharmaceutica Company Information
 Table 91. Santen Pharmaceutica Description and Business Overview
 Table 92. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Santen Pharmaceutica Ophthalmic Medicine Product
 Table 94. Santen Pharmaceutica Recent Developments/Updates
 Table 95. Bausch Health Company Information
 Table 96. Bausch Health Description and Business Overview
 Table 97. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bausch Health Ophthalmic Medicine Product
 Table 99. Bausch Health Recent Developments/Updates
 Table 100. Alcon NV Company Information
 Table 101. Alcon NV Description and Business Overview
 Table 102. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Alcon NV Ophthalmic Medicine Product
 Table 104. Alcon NV Recent Developments/Updates
 Table 105. Mentholatum Company Information
 Table 106. Mentholatum Description and Business Overview
 Table 107. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mentholatum Ophthalmic Medicine Product
 Table 109. Mentholatum Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Ophthalmic Medicine Distributors List
 Table 113. Ophthalmic Medicine Customers List
 Table 114. Ophthalmic Medicine Market Trends
 Table 115. Ophthalmic Medicine Market Drivers
 Table 116. Ophthalmic Medicine Market Challenges
 Table 117. Ophthalmic Medicine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ophthalmic Medicine
 Figure 2. Global Ophthalmic Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ophthalmic Medicine Market Share by Type: 2024 & 2031
 Figure 4. Eye Drops Product Picture
 Figure 5. Eye Ointment Product Picture
 Figure 6. Gelling Agent Product Picture
 Figure 7. Tablet Product Picture
 Figure 8. Injection Product Picture
 Figure 9. Global Ophthalmic Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Ophthalmic Medicine Market Share by Application: 2024 & 2031
 Figure 11. Anti-fatigue and Dryness
 Figure 12. Cataract
 Figure 13. Anti-infective
 Figure 14. Global Ophthalmic Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Ophthalmic Medicine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Ophthalmic Medicine Sales (2020-2031) & (K Units)
 Figure 17. Global Ophthalmic Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 18. Ophthalmic Medicine Report Years Considered
 Figure 19. Ophthalmic Medicine Sales Share by Manufacturers in 2024
 Figure 20. Global Ophthalmic Medicine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Ophthalmic Medicine Players: Market Share by Revenue in Ophthalmic Medicine in 2024
 Figure 22. Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Ophthalmic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Ophthalmic Medicine Sales Market Share by Country (2020-2031)
 Figure 25. North America Ophthalmic Medicine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Ophthalmic Medicine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Ophthalmic Medicine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Ophthalmic Medicine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Ophthalmic Medicine Revenue Market Share by Region (2020-2031)
 Figure 37. China Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Ophthalmic Medicine Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Ophthalmic Medicine Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Ophthalmic Medicine Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Ophthalmic Medicine Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Ophthalmic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Ophthalmic Medicine by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Ophthalmic Medicine by Type (2020-2031)
 Figure 58. Global Ophthalmic Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Ophthalmic Medicine by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Ophthalmic Medicine by Application (2020-2031)
 Figure 61. Global Ophthalmic Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 62. Ophthalmic Medicine Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Ophthalmic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Gel Market Research Report 2024
Ophthalmology Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Conjunctivitis Treatment Eye Drops Market Research Report 2024
Eye Drops Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Imaging Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmic Devices and Drugs Market Research Report 2025
Global One Stop Ophthalmic Medical Solution Market Research Report 2024
Ophthalmol Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opthalmic Lenses Market
Global Ophthalmic Combination Product Market Research Report 2024
Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology Packaging Market Research Report 2024
Ophthalmology Medical Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eyedrops Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions